Successful use of palliative inotrope therapy in end-stage cardiac ATTR amyloidosisdoi:10.1080/13506129.2017.1372412Muhammad SPanhwarSadeerAl-KindiGuilherme HOliveiraMahazarinGinwallaAmyloid : the international journal of experimental and clinical investigation : the official journal of the International Society...
Successful use of palliative inotrope therapy in end-stage cardiac ATTR amyloidosis Successful use of palliative inotrope therapy in end-stage cardiac ATTR amyloidosisTo understand the relationship of autoimmune diseases and heart failuredoi:10.1080/13506129.2017.1372412Panhwar, Muhammad S... MS Panhwar,S...
Cardiac evaluation (pretransplant and post-transplant period) In accordance with our standard pretransplant evaluation protocol, all potential recipients ≥50 years old, as well as patients of any age with a history of diabetes mellitus (type 1 or 2) or ischemic heart disease, were evaluated for...
Cardiac involvement occurs in light-chain (AL), transthyretin wild-type (wtATTR), and hereditary (hATTR) amyloidosis; other types of amyloidosis account for<5% of all cardiac amyloidosis (CA). CA can present subclinically on screening, insidiously with symptoms such as exertional dyspnea, or ...
Successful use of palliative inotrope therapy in end-stage cardiac ATTR amyloidosis 来自 Semantic Scholar 喜欢 0 阅读量: 9 作者: Panhwar, Muhammad S.,Al-Kindi, Sadeer,Oliveira, Guilherme H.,Ginwalla, Mahazarin 摘要: To understand the relationship of autoimmune diseases and heart failure ...
TRANSFER OF CARE LEADING TO TOTAL ARTIFICIAL HEART AS BRIDGE TO TRANSPLANT IN END STAGE CARDIAC AMYLOIDOSISPeripheral arterial disease (PAD) is a condition typified by decreased arterial blood flow in the non-coronary branches of the aorta as a result of chronic atherosclerosis. Despite the higher ...
Immunoglobulin light chain (AL) amyloidosis is a multisystem disease with varied treatment options and disease-related outcomes. Current staging systems rely on a limited number of cardiac, renal, and plasma cell dyscrasia biomarkers. To improve prognostication for all-cause mortality and end-stage ...
Cardiac amyloidosis is one of the most common of the infiltrative cardiomyopathies and is associated with a poor prognosis. The extent of cardiac involvement with amyloid deposition is an important determinant of treatment options and is the major determinant of outcome in patients with amyloidosis....